Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv™ (Etelcalcetide ... - PR Newswire (press release)

Submitted by Anonymous (not verified) on Tue, 01/10/2017 - 21:15

Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv™ (Etelcalcetide ...PR Newswire (press release)10, 2017 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the Journal of the American Medical Association (JAMA) publication of findings from three Phase 3 studies of Parsabiv™ (etelcalcetide), an investigational intravenous calcimimetic agent ...and more »